title: Elucidation of toxicity pathways in lung epithelial cells induced by silicon dioxide nanoparticles.
abstract: A study into the effects of amorphous nano-SiO2 particles on A549 lung epithelial cells was undertaken using proteomics to understand the interactions that occur and the biological consequences of exposure of lung to nanoparticles. Suitable conditions for treatment, where A549 cells remained viable for the exposure period, were established by following changes in cell morphology, flow cytometry, and MTT reduction. Label-free proteomics was used to estimate the relative level of proteins from their component tryptic peptides detected by mass spectrometry. It was found that A549 cells tolerated treatment with 100 µg/ml nano-SiO2 in the presence of 1.25% serum for at least 4 h. After this time detrimental changes in cell morphology, flow cytometry, and MTT reduction were evident. Proteomics performed after 4 h indicated changes in the expression of 47 proteins. Most of the proteins affected fell into four functional groups, indicating that the most prominent cellular changes were those that affected apoptosis regulation (e.g. UCP2 and calpain-12), structural reorganisation and regulation of actin cytoskeleton (e.g. PHACTR1), the unfolded protein response (e.g. HSP 90), and proteins involved in protein synthesis (e.g. ribosomal proteins). Treatment with just 10 µg/ml nano-SiO2 particles in serum-free medium resulted in a rapid deterioration of the cells and in medium containing 10% serum the cells were resistant to up to 1000 µg/ml nano-SiO2 particles, suggesting interaction of serum components with the nanoparticles. A variety of serum proteins were found which bound to nano-SiO2 particles, the most prominent of which were albumin, apolipoprotein A-I, hemoglobin, vitronectin and fibronectin. The use of a proteomics platform, with appropriately designed experimental conditions, enabled the early biological perturbations induced by nano-SiO2 in a model target cell system to be identified. The approach facilitates the design of more focused test systems for use in tiered evaluations of nanomaterials.
authors.affiliation: Division of Experimental Medicine, Department of Medicine, Imperial College London, London, United Kingdom.
authors.forename: Odu
authors.initials: O
authors.lastname: Okoturo-Evans
authors.forename: Agnieszka
authors.initials: A
authors.lastname: Dybowska
authors.forename: Eugenia
authors.initials: E
authors.lastname: Valsami-Jones
authors.forename: John
authors.initials: J
authors.lastname: Cupitt
authors.forename: Magdalena
authors.initials: M
authors.lastname: Gierula
authors.forename: Alan R
authors.initials: AR
authors.lastname: Boobis
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Edwards
mesh_terms: D045744:Cell Line, Tumor; D004847:Epithelial Cells / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D015151:Immunoblotting; D053758:Nanoparticles / Q000633:toxicity*; D015398:Signal Transduction / Q000187:drug effects; D012822:Silicon Dioxide / Q000633:toxicity*
chemical_list: D012822:Silicon Dioxide
references.citation: Nat Nanotechnol. 2013 Feb;8(2):69
references.pmid: 23380920
references.citation: Toxicol Pathol. 1997 Jan-Feb;25(1):82-8
references.pmid: 9061857
references.citation: PLoS One. 2009 Dec 24;4(12):e8436
references.pmid: 20041182
references.citation: Biochimie. 2011 Oct;93(10):1668-75
references.pmid: 21798305
references.citation: J Immunol Methods. 1983 Dec 16;65(1-2):55-63
references.pmid: 6606682
references.citation: Part Fibre Toxicol. 2011 Jul 27;8:22
references.pmid: 21794132
references.citation: Int J Hyg Environ Health. 2011 Jun;214(3):231-8
references.pmid: 21168363
references.citation: Sangyo Eiseigaku Zasshi. 2008 Mar;50(2):37-48
references.pmid: 18388452
references.citation: Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2877-82
references.pmid: 18287014
references.citation: Pflugers Arch. 2007 Sep;454(6):879-89
references.pmid: 17361457
references.citation: Ann Occup Hyg. 2009 Apr;53(3):225-37
references.pmid: 19279163
references.citation: Toxicol In Vitro. 2013 Feb;27(1):24-33
references.pmid: 22985735
references.citation: Eur Phys J E Soft Matter. 2009 Oct;30(2):175-9
references.pmid: 19551415
references.citation: Med J Aust. 2007 Feb 19;186(4):187-8
references.pmid: 17309420
references.citation: Part Fibre Toxicol. 2011 Dec 30;8:36
references.pmid: 22208550
references.citation: Acc Chem Res. 2013 Mar 19;46(3):743-9
references.pmid: 22786674
references.citation: Inhal Toxicol. 2012;24(2):125-35
references.pmid: 22260506
references.citation: Crit Rev Toxicol. 2011 Jan;41(1):22-49
references.pmid: 21077788
references.citation: Physiol Rev. 2007 Jan;87(1):99-163
references.pmid: 17237344
references.citation: Asian Pac J Cancer Prev. 2009;10(6):975-80
references.pmid: 20192569
references.citation: Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2012 Aug;29(8):1175-82
references.pmid: 22725966
references.citation: Proteomics. 2011 Jun;11(12):2406-22
references.pmid: 21595037
references.citation: Environ Sci Technol. 2008 Dec 1;42(23):8985-92
references.pmid: 19192829
references.citation: Clin Dermatol. 2010 Sep-Oct;28(5):581-8
references.pmid: 20797523
references.citation: Microsc Res Tech. 2003 Nov 1;62(4):336-55
references.pmid: 14534907
references.citation: Circulation. 2010 Nov 16;122(20):2058-67
references.pmid: 21041689
references.citation: Exp Cell Res. 1998 Sep 15;243(2):359-66
references.pmid: 9743595
references.citation: Toxicol Lett. 2011 Oct 10;206(2):197-203
references.pmid: 21803137
references.citation: Inhal Toxicol. 2010 Dec;22 Suppl 2:95-9
references.pmid: 20936915
references.citation: ACS Nano. 2012 Jul 24;6(7):5845-57
references.pmid: 22721453
references.citation: Nanotechnology. 2009 Nov 11;20(45):455101
references.pmid: 19822937
references.citation: ACS Nano. 2010 Jul 27;4(7):3580-90
references.pmid: 20695513
references.citation: Toxicol In Vitro. 2010 Apr;24(3):751-8
references.pmid: 20060462
references.citation: Drug Discov Today. 2012 Oct;17(19-20):1147-54
references.pmid: 22772028
references.citation: Hum Exp Toxicol. 2013 Feb;32(2):153-66
references.pmid: 23111874
references.citation: Chem Res Toxicol. 2012 Oct 15;25(10):2227-35
references.pmid: 22931364
references.citation: Hum Exp Toxicol. 2013 Feb;32(2):186-95
references.pmid: 23315277
references.citation: EFSA J. 2018 Jul 04;16(7):e05327
references.pmid: 32625968
references.citation: Nanomedicine. 2007 Jun;3(2):111-9
references.pmid: 17572353
references.citation: Toxicol Sci. 2011 Mar;120 Suppl 1:S109-29
references.pmid: 21177774
references.citation: Cytometry. 2000 Feb 15;42(1):74-8
references.pmid: 10679746
references.citation: Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009 Nov-Dec;1(6):660-70
references.pmid: 20049823
references.citation: Science. 2011 Nov 25;334(6059):1081-6
references.pmid: 22116877
references.citation: J Am Chem Soc. 2011 Mar 2;133(8):2525-34
references.pmid: 21288025
references.citation: ACS Nano. 2011 Sep 27;5(9):7503-9
references.pmid: 21861491
references.citation: Part Fibre Toxicol. 2010 Jan 19;7:1
references.pmid: 20180970
references.citation: Anal Biochem. 1985 Oct;150(1):76-85
references.pmid: 3843705
references.citation: Small. 2011 May 23;7(10):1322-37
references.pmid: 21520409
references.citation: Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2012 Aug;29(8):1183-93
references.pmid: 22725833
references.citation: PLoS One. 2012;7(1):e30714
references.pmid: 22292025
references.citation: Acc Chem Res. 2013 Mar 19;46(3):607-21
references.pmid: 22676423
references.citation: J Proteomics. 2011 Nov 18;74(12):2703-12
references.pmid: 21406258
references.citation: Part Fibre Toxicol. 2010 Aug 21;7:22
references.pmid: 20727197
references.citation: Anal Bioanal Chem. 2011 May;400(5):1367-73
references.pmid: 21479547
references.citation: Annu Rev Biomed Eng. 2012;14:1-16
references.pmid: 22524388
references.citation: Cell Death Differ. 2009 Jan;16(1):3-11
references.pmid: 18846107
references.citation: Cell Death Differ. 2009 Jan;16(1):70-8
references.pmid: 19008921
references.citation: J Am Chem Soc. 2010 Apr 28;132(16):5761-8
references.pmid: 20356039
references.citation: Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):733-9
references.pmid: 10934113
references.citation: Toxicol Sci. 2012 Mar;126(1):149-61
references.pmid: 22157353
references.citation: Int J Nanomedicine. 2011;6:1889-901
references.pmid: 21931484
references.citation: Proteomics. 2008 May;8(10):1987-2005
references.pmid: 18491314